At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 79 enrolled
Drug / intervention
Intrathecal morphine +1 moredrug
Likely dose
Intrathecal morphine 5 microgramsfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized, Double Blinded, Trial Comparing Intrathecal Morphine With Placebo in Patients Undergoing Robotic Totally Endoscopic Beating Heart Coronary Revascularization and Intraoperative Extubation
In Brief
A Phase 4 clinical trial evaluating Intrathecal morphine and Placebo for Pain. Completed, enrolled 79 participants across 1 site.
Detailed Summary
This is a randomized clinical trial in patients undergoing robotic myocardial revascularization with intraoperative extubation. Patients will be randomized into placebo or intrathecal morphine groups to assess postoperative pain scores and patient satisfaction. Patients will also be assessed for side effects from the intervention.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
201820192020202120222023202420252026
First PostedAug 2017
Enrollment StartJun 2018
Primary CompletionSep 2020
TodayJul 2026
First PostedAug 7, 2017
Enrollment StartJun 19, 2018
Primary CompletionSep 1, 2020
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 8.9 years ago
Interventions
Intrathecal morphinedrug
5 micrograms/kilogram of intrathecal morphine administered in the spinal space, not to exceed 1mg
Placebodrug
Saline intrathecal given in the same manner as the intervention groups.